Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News ALTA-1L trial results : Takeda’s ALUNBRIG continues to show superiority over crizotinib ALTA-1L trial results : Takeda Pharmaceutical says that ALUNBRIG (brigatinib), its tyrosine kinase inhibitor (TKI), is continuing to… bypharmanewsdailyNovember 23, 2019
